
Bad news
#1
Posted 26 November 2016 - 10:04 AM
1/2016 -- 0.7
3/2016 -- 0.6
We decided to move to 600 gleevec in 4/2016. Then ...
6/2016 -- 0.4
8/2016 -- 0.1
11/2016 -- 0.4
So it's moving up, and I have nowhere to go. I have to be careful with the second generation stuff because I have a bad heart.
Does anyone else fit my profile? If I'm forced to go to say, tasigna, what can I expect?
Diagnosed in February 2014. Started Imatinib 400 in April.
2014: 3.18 0.91
2015: 0.22 0.16 0.04 0.55
2016: 0.71 0.66
(Started Imatinib 600 in April 2016)
2016: 0.42 0.13 0.45
2017: 0.17 0.06 0.10 0.06 0.34
#2
Posted 26 November 2016 - 11:05 AM
You are hanging around MMR levels, which is good overall. The variations you have seen are not unusual. You could continue on the same track, or switch drugs if you want, but I understand the hesitation due to heart issues and the uncertainty about the other drugs.
In the first large group of Gleevec users (IRIS Trial) some patients took many years taking Gleevec to drop below MMR levels. So that could still happen to you. Since your PCRs are stable enough, it is an option to just continue what you are doing unless you see a large spike in PCR (increase by 1 log, which would be to about 4% for you).
#3
Posted 28 November 2016 - 10:59 AM
Try not to be sad and negative about it as it will affect your health. Have you tried changing your diet? I have reduced my intake of fried and oily food, less processed and sugary things. I used to drink pure wheat grass juice and also a fruit mixture consisting of apple, beet root and carrot. Maybe you can give it a try?
#4
Posted 28 November 2016 - 09:16 PM
Diagnosed in February 2014. Started Imatinib 400 in April.
2014: 3.18 0.91
2015: 0.22 0.16 0.04 0.55
2016: 0.71 0.66
(Started Imatinib 600 in April 2016)
2016: 0.42 0.13 0.45
2017: 0.17 0.06 0.10 0.06 0.34
#5
Posted 28 November 2016 - 11:26 PM
#6
Posted 29 November 2016 - 12:28 PM
Dom - I don't know what your heart issues are, but have you thought of Sprycel? The reason I suggest it is that it is of a different makeup than Gleevec or Tasigna, and people who "stick" on Gleevec often "unstick" and zoom downward with Sprycel. This is what happened to me. I had not quite nailed MMR at two years in on Gleevec and when I switched to Sprycel (only because of side effects) I immediately got it. That zero to the right of the decimal point also came along pretty quick and has - fingers crossed - stayed for the past four years. But even with your current numbers, you're pretty safe. My onc told me recently that he has many, many patients at very low levels (which is what he would call MMR) who just hover there, year after year after year. Not what you want to hear when everyone is talking about TFR and dose reduction, but it does offer some perspective.
Dx July 2009 on routine physical. WBC 94. Started Gleevec 400 mg Sept 2009. MMR at 2yrs. Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved. Kidney issues developed because of Gleevec. Switched to Sprycel 70 mg in Aug 2011. Above side effects disappeared or improved. Have been MR3.5 - 4.5 ever since. Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017. After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS. Pleural effusion returned within a couple of months, same as before (moderate, left side only). Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved. At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.
#7
Posted 29 November 2016 - 01:03 PM
Do you know if sprycel has any cardio side effects?
Diagnosed in February 2014. Started Imatinib 400 in April.
2014: 3.18 0.91
2015: 0.22 0.16 0.04 0.55
2016: 0.71 0.66
(Started Imatinib 600 in April 2016)
2016: 0.42 0.13 0.45
2017: 0.17 0.06 0.10 0.06 0.34
#8
Posted 29 November 2016 - 03:48 PM
I don't know of any other than they are now seeing some cardiovascular "events" in older, longterm patients, but I believe that's for all TKI's, not Sprycel in particular. I could be wrong on that. At any rate, why don't you take a look at the patient insert for Sprycel online - if there's anything, it should be there. And Trey could chime in here?
Dx July 2009 on routine physical. WBC 94. Started Gleevec 400 mg Sept 2009. MMR at 2yrs. Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved. Kidney issues developed because of Gleevec. Switched to Sprycel 70 mg in Aug 2011. Above side effects disappeared or improved. Have been MR3.5 - 4.5 ever since. Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017. After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS. Pleural effusion returned within a couple of months, same as before (moderate, left side only). Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved. At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.
#9
Posted 29 November 2016 - 08:08 PM
#10
Posted 29 November 2016 - 09:54 PM
Diagnosed in February 2014. Started Imatinib 400 in April.
2014: 3.18 0.91
2015: 0.22 0.16 0.04 0.55
2016: 0.71 0.66
(Started Imatinib 600 in April 2016)
2016: 0.42 0.13 0.45
2017: 0.17 0.06 0.10 0.06 0.34
#11
Posted 29 November 2016 - 10:59 PM
#12
Posted 10 December 2016 - 05:47 PM
If I remember correctly, Sprycel can cause fluid in the lungs and abnormal heart rate . I had looked this drug up after starting Gleevec. I
wanted to know which of the others - tasigna or sprycel she could take if she failed to get molecular remission with Gleevec. The answer was that she couldn't take either tasigna nor sprycel. He has a heart condition called hyperventricular tachycardia. This is something that she was diagnosed with in her 20's.
#13
Posted 11 December 2016 - 01:11 AM
#14
Posted 12 December 2016 - 09:24 AM
Thanks, peanut. Interesting that the cardiologist picked sprycel over Gleevec because of heart issues.
Early on there were thought to be problems with Gleevec and what is called Long QT, the timing between heart beats. Apparently one of the early patients in the earliest trials died of complications resulting from the Long QT problem that he brought to the trial. My Mrs wore a monitor for a week, got it all checked out, they had the info sent out to a few different oncs, Druker among them. This would have been late 2006. It was pretty quickly established that Gleevec didn't bring on Long QT problems and it didn't exacerbate them, that people develop Long QT for other reasons. But they kept people with known Long QT problems off of it once there were new drugs.
That hasn't stopped the belief in Gleevec and heart issues of all kinds though.
rct
#15
Posted 13 February 2017 - 08:00 PM
1/2017 -- 0.1.
This month I move to generic. Hope nothing changes. Right now, I'm feeling pretty good.
Diagnosed in February 2014. Started Imatinib 400 in April.
2014: 3.18 0.91
2015: 0.22 0.16 0.04 0.55
2016: 0.71 0.66
(Started Imatinib 600 in April 2016)
2016: 0.42 0.13 0.45
2017: 0.17 0.06 0.10 0.06 0.34
#16
Posted 13 February 2017 - 08:15 PM
Just wanted to follow up with everyone. The bad news of the title is now (somewhat) good news. My last test came back with 0.1. So it is bouncing around between 0.4 and 0.1. You can add this to the numbers of my original post.
1/2017 -- 0.1.
This month I move to generic. Hope nothing changes. Right now, I'm feeling pretty good.
That's good news Dom. Congratulations!
For the benefit of yourself and others please add your CML history into your Signature
02/2010 Gleevec 400mg
2011 Two weakly positives, PCRU, weakly positive
2012 PCRU, PCRU, PCRU, PCRU
2013 PCRU, PCRU, PCRU, weakly positive
2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)
2015 300, 250, 200, 150
2016 100, 50/100, 100, 10/17 TFR
2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000
2018 01/16 TFR 0.0004 ... next quarterly PCR 04/17
At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.
In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.
longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation. GFR and creatinine vastly improved after stopping Gleevec.
Cumulative Gleevec dosage estimated at 830 grams
Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.
Trey's CML Blog - Stopping - The Odds - Stop Studies - Discussion Forum Cessation Study
Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt
#17
Posted 14 February 2017 - 08:59 AM
If your PCR goes up again in the future, you can always switch to Bosulif, I believe that it has the same side effects profile as Gleevec (or close to it) on the heart and not as hard on the heart as Sprycel and Tasigna.
08/2015 Initial PCR: 66.392%
12/2015 PCR: 1.573%
03/2016 PCR: 0.153%
06/2016 PCR: 0.070%
09/2016 PCR: 0.052%
12/2016 PCR: 0.036%
03/2017 PCR: 0.029%
06/2017 PCR: 0.028%
09/2017 PCR: 0.025%
12/2017 PCR: 0.018%
Taking Imatinib 400 mg
#18
Posted 14 February 2017 - 05:18 PM
I was relatively slow on 400mg Gleevec. I had a CCyR by 18 months and hung out in the 2.5-2.8 log reduction range after that. My doctor did a mutation test and I found out I had the E453K mutation. There's little data on it but has been shown to be mildly resistant to Gleevec. Since I tolerate the medication extremely well, we decided to up the dosage to 600mg Gleevec. After about 1.5 years at the higher dosage (with some fluctuations) I'm consistently now in the 3.5-3.8 log reduction zone. I'm 4.5 years into my diagnosis. I'd give it time for the increased dosage to kick in.
Diagnosed with CML in July 2012 (33 years old)
MMR since March 2015; E453K mutation
600mg Gleevec
#19
Posted 14 February 2017 - 06:16 PM
Diagnosed in February 2014. Started Imatinib 400 in April.
2014: 3.18 0.91
2015: 0.22 0.16 0.04 0.55
2016: 0.71 0.66
(Started Imatinib 600 in April 2016)
2016: 0.42 0.13 0.45
2017: 0.17 0.06 0.10 0.06 0.34
#20
Posted 14 February 2017 - 07:12 PM
0.32 is MR2.5 (log reduction 2.5)
0.1 is MR3 also referred to as MMR
0.032 is MR3.5 (log reduction 3.5)
0.01 is MR4
0.0032 is MR4.5 (log reduction 4.5)
0.001 is MR5
For the benefit of yourself and others please add your CML history into your Signature
02/2010 Gleevec 400mg
2011 Two weakly positives, PCRU, weakly positive
2012 PCRU, PCRU, PCRU, PCRU
2013 PCRU, PCRU, PCRU, weakly positive
2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)
2015 300, 250, 200, 150
2016 100, 50/100, 100, 10/17 TFR
2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000
2018 01/16 TFR 0.0004 ... next quarterly PCR 04/17
At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.
In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.
longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation. GFR and creatinine vastly improved after stopping Gleevec.
Cumulative Gleevec dosage estimated at 830 grams
Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.
Trey's CML Blog - Stopping - The Odds - Stop Studies - Discussion Forum Cessation Study
Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users